000			01928nam a22004337a 4500
008			210607s20212021 xxu||||| |||| 00| 0 eng d
022			_a0735-6757
024			_a10.1016/j.ajem.2021.03.075 [doi]
024			_aS0735-6757(21)00264-3 [pii]
040			_aOvid MEDLINE(R)
099			_a33838936
245			_aThe role of co-administration of magnesium sulfate with QTc-prolonging medications in the emergency department. [Review]
251			_aAmerican Journal of Emergency Medicine. 52:232-234, 2022 02.
252			_aAm J Emerg Med. 52:232-234, 2022 02.
252			_zAm J Emerg Med. 2021 Mar 27
253			_aThe American journal of emergency medicine
260			_c2022
260			_fFY202
265			_saheadofprint
265			_sppublish
266			_d2021-06-07
268			_aAmerican Journal of Emergency Medicine. 2021 Mar 27
269			_fFY2021
546			_aEnglish
650			_a*Anti-Arrhythmia Agents/ad [Administration & Dosage]
650			_a*Long QT Syndrome/dt [Drug Therapy]
650			_a*Magnesium Sulfate/ad [Administration & Dosage]
650			_aDrug Therapy, Combination
650			_aEmergency Service, Hospital/og [Organization & Administration]
650			_aHumans
651			_aMedStar Washington Hospital Center
656			_aEmergency Medicine
657			_aLetter
700			_aAmirshahi, Maryann
790			_aHodgson R, Hoffer M, Mazer-Amirshahi M, Pourmand A
856			_uhttps://dx.doi.org/10.1016/j.ajem.2021.03.075 _zhttps://dx.doi.org/10.1016/j.ajem.2021.03.075 _zhttps://dx.doi.org/10.1016/j.ajem.2021.03.075xl - https://dx.doi.org/10.1016/j.ajem.2021.03.075
856			_uhttps://dx.doi.org/10.1016/j.ajem.2021.03.075xl - https://dx.doi.org/10.1016/j.ajem.2021.03.075 _zhttps://dx.doi.org/10.1016/j.ajem.2021.03.075 _zhttps://dx.doi.org/10.1016/j.ajem.2021.03.075xl - https://dx.doi.org/10.1016/j.ajem.2021.03.075
942			_cART _dArticle
999			_c6323 _d6323